Interference in antiphospholipid antibody assays

Seminars in Thrombosis and Hemostasis

Volumn 38, Issue 4, 2012, Pages 353-359

  Lakos, Gabriella ^a  

^a INOVA DIAGNOSTICS INC   (United States)

Author keywords

anticoagulants; antiphospholipid immunoassays; heterophile antibodies; lupus anticoagulant; rheumatoid factor

Indexed keywords

ANTICOAGULANT AGENT; BILIRUBIN; CROSS REACTING ANTIBODY; HEMOGLOBIN; HETEROPHILE ANTIBODY; PARAPROTEIN; PHOSPHOLIPID ANTIBODY; RHEUMATOID FACTOR;

HUMAN; HYPERLIPIDEMIA; IMMUNOASSAY; INTERFERENCE; LABORATORY TEST; MEASUREMENT ERROR; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; REVIEW; THROMBOCYTE;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; FEMALE; HUMANS; IMMUNOASSAY; MICE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84861346177     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0032-1304714     Document Type: Review

References (58)

1. Clinical and Laboratory Standards Institute (CLSI). Interference Testing in Clinical Chemistry; Approved Guideline-Second Edition. CLSI document EP7-A2. Wayne, PA Clinical and Laboratory Standards Institute: 2005
2. Ismail AA, Walker PL, Cawood ML, Barth JH. Interference in immunoassay is an underestimated problem. Ann Clin Biochem: 2002; 39 Pt 4 366 373 (Pubitemid 34743638)
3. Cole LA, Rinne KM, Shahabi S, Omrani A. False-positive hCG assay results leading to unnecessary surgery and chemotherapy and needless occurrences of diabetes and coma. Clin Chem: 1999; 45 2 313 314 (Pubitemid 29079143)
4. Desprs N, Grant AM. Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem: 1998; 44 3 440 454 (Pubitemid 28141337)
5. Miyakis S, Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost: 2006; 4 2 295 306
6. Clinical and Laboratory Standards Institute (CLSI). Immunoassay Interference by Endogeneous Antibodies; Approved Guideline. CLSI document I/LA30-A. Clinical and Laboratory Standards Institute Wayne, PA: 2008
7. Kano K, Merrick JM, Milgrom F. Classification of human heterophile antibodies. Int Arch Allergy Appl Immunol: 1984; 73 4 373 377 (Pubitemid 14161493)
8. Boscato LM, Stuart MC. Incidence and specificity of interference in two-site immunoassays. Clin Chem: 1986; 32 8 1491 1495 (Pubitemid 17027766)
9. Patarca R, Fletcher MA. Structure and pathophysiology of the erythrocyte membrane-associated Paul-Bunnell heterophile antibody determinant in Epstein-Barr virus-associated disease. Crit Rev Oncog: 1995; 6 3-6 305 326 (Pubitemid 27080910)
10. Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev: 2004; 25 2 105 120
11. Preissner CM, O'Kane DJ, Singh RJ, Morris JC, Grebe SK. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab: 2003; 88 7 3069 3074 (Pubitemid 36877474)
12. Willman JH, Martins TB, Jaskowski TD, Hill HR, Litwin CM. Heterophile antibodies to bovine and caprine proteins causing false-positive human immunodeficiency virus type 1 and other enzyme-linked immunosorbent assay results. Clin Diagn Lab Immunol: 1999; 6 4 615 616 (Pubitemid 29330753)
13. Spencer DV, Nolte FS, Zhu Y. Heterophilic antibody interference causing false-positive rapid human immunodeficiency virus antibody testing. Clin Chim Acta: 2009; 399 1-2 121 122
14. Levinson SS, Miller JJ. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta: 2002; 325 1-2 1 15 (Pubitemid 35279621)
15. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem: 1999; 45 7 942 956 (Pubitemid 29340529)
16. Klee GG. Human anti-mouse antibodies. Arch Pathol Lab Med: 2000; 124 6 921 923 (Pubitemid 30397589)
17. Kricka LJ, Schmerfeld-Pruss D, Senior M, Goodman DB, Kaladas P. Interference by human anti-mouse antibody in two-site immunoassays. Clin Chem: 1990; 36 6 892 894
18. Rothberg RM, Farr RS. Anti-bovine serum albumin and anti-alpha lactalbumin in the serum of children and adults. Pediatrics: 1965; 35 571 588
19. Berth M, Bosmans E, Everaert J., et al. Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9). Clin Chem Lab Med: 2006; 44 9 1137 1139 (Pubitemid 44370937)
20. Barcel Martn B, Marquet P, Ferrer JM., et al. Rheumatoid factor interference in a tacrolimus immunoassay. Ther Drug Monit: 2009; 31 6 743 745
21. Norden AG, Jackson RA, Norden LE, Griffin AJ, Barnes MA, Little JA. Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor. Clin Chem: 1997; 43 6 Pt 1 957 962 (Pubitemid 27246985)
22. Shmerling RH, Delbanco TL. The rheumatoid factor: an analysis of clinical utility. Am J Med: 1991; 91 5 528 534
23. Stevenson DL, Harris AG, Neal KR, Irving WL.; Trent HCV Study Group. The presence of rheumatoid factor in sera from anti-HCV positive blood donors interferes with the detection of HCV-specific IgM. J Hepatol: 1996; 25 5 621 626 (Pubitemid 26373876)
24. Meurman OH, Ziola BR. IgM-class rheumatoid factor interference in the solid-phase radioimmunoassay of rubella-specific IgM antibodies. J Clin Pathol: 1978; 31 5 483 487 (Pubitemid 8333049)
25. Champsaur H, Fattal-German M, Arranhado R. Sensitivity and specificity of viral immunoglobulin M determination by indirect enzyme-linked immunosorbent assay. J Clin Microbiol: 1988; 26 2 328 332 (Pubitemid 18054954)
26. Wong RC, Gillis D, Adelstein S., et al. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology: 2004; 36 1 63 68 (Pubitemid 38223415)
27. Wong RC, Favaloro EJ, Adelstein S., et al. Consensus guidelines on anti- 2 glycoprotein I testing and reporting. Pathology: 2008; 40 1 58 63 (Pubitemid 350172955)
28. Pierangeli SS, Harris EN. A protocol for determination of anticardiolipin antibodies by ELISA. Nat Protoc: 2008; 3 5 840 848 (Pubitemid 351639028)
29. Tincani A, Allegri F, Balestrieri G., et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res: 2004; 114 5-6 553 558 (Pubitemid 39422591)
30. Reber G, Tincani A, Sanmarco M, de Moerloose P, Boffa MC.; Standardization group of the European Forum on Antiphospholipid Antibodies. Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost: 2004; 2 1860 1862 (Pubitemid 40192732)
31. Galperin I, Fortin PR, Subang R, Newkirk MM, Rauch J. A subset of rheumatoid factors crossreacts with cardiolipin in patients positive for IgM rheumatoid factor and anticardiolipin antibodies. J Rheumatol: 2000; 27 3 820 821 (Pubitemid 30151373)
32. Agopian MS, Boctor FN, Peter JB. False-positive test result for IgM anticardiolipin antibody due to IgM rheumatoid factor. Arthritis Rheum: 1988; 31 9 1212 1213
33. Lakos G, Teodorescu M. IgM, but not IgA rheumatoid factor interferes with anti-cardiolipin and anti2 glycoprotein I measurements: a quantitative analysis. Lupus: 2011; 20 6 614 619
34. Villalta D, Crovatto M, Stella S, Tonutti E, Tozzoli R, Bizzaro N. False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent. Clin Chim Acta: 2005; 356 1-2 102 109 (Pubitemid 40779890)
35. Bizzaro N, Tampoia M, Villalta D., et al. Low specificity of anti-tissue transglutaminase antibodies in patients with primary biliary cirrhosis. J Clin Lab Anal: 2006; 20 5 184 189 (Pubitemid 44412090)
36. Vermeersch P, Coenen D, Geboes K, Marin G, Hiele M, Bossuyt X. Use of likelihood ratios improves clinical interpretation of IgA anti-tTG antibody testing for celiac disease. Clin Chim Acta: 2010; 411 1-2 13 17
37. Kumar V, Bartholomew W, Shieh MT, Pierce C, Kaul N. Standardization of ELISA for the detection of anti-cardiolipin antibodieseffect of non-specific IgG binding. Immunol Invest: 1991; 20 7 583 593
38. Cowchock S, Fort J, Munoz S, Norberg R, Maddrey W. False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion. Clin Exp Immunol: 1988; 73 2 289 294
39. Bizzaro N, Pasini P, Finco B. False-positive reactions for IgA anti-phospholipid and anti-beta(2)-glycoprotein I antibodies in patients with IgA monoclonal gammopathy. Clin Chem: 1999; 45 11 2007 2010 (Pubitemid 29522011)
40. Roubey RA. Antigenic specificities of antiphospholipid autoantibodies: implications for clinical laboratory testing and diagnosis of the antiphospholipid syndrome. Lupus: 1996; 5 5 425 430 (Pubitemid 26354059)
41. Smeenk RJ, Lucassen WA, Swaak TJ. Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity? Arthritis Rheum: 1987; 30 6 607 617 (Pubitemid 17104899)
42. Hunt JE, McNeil HP, Morgan GJ, Crameri RM, Krilis SA. A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus: 1992; 1 2 75 81
43. Pengo V, Biasiolo A, Fior MG. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface. Thromb Haemost: 1995; 73 1 29 34
44. Clinical and Laboratory Standards Institute (CLSI). Collection, Transport and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays: Approved Guideline-Fifth Edition. CLSI document H21-A5. Clinical and Laboratory Standards Institute Wayne, PA: 2008
45. Pengo V, Tripodi A, Reber G., et al. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost: 2009; 7 10 1737 1740
46. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost: 1995; 74 4 1185 1190
47. Brien WF, Schaus MR, Cooper KE, O'Keefe BT, Inwood M. Lupus anticoagulant testing: effect of the platelet count on the activated partial thromboplastin time. Br J Biomed Sci: 1993; 50 2 114 116 (Pubitemid 23316846)
48. Tripodi A. Laboratory testing for lupus anticoagulants: a review of issues affecting results. Clin Chem: 2007; 53 9 1629 1635 (Pubitemid 47340059)
49. Tripodi A, Biasiolo A, Chantarangkul V, Pengo V. Lupus anticoagulant (LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity. Clin Chem: 2003; 49 10 1608 1614 (Pubitemid 37194214)
50. Sangle NA, Rodgers GM, Smock KJ. Prevalence of heparin in samples submitted for lupus anticoagulant testing. Lab Hematol: 2011; 17 1 6 11
51. Jacobsen EM, Trettenes EJ, Wislff F, Abildgaard U. Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene. Thromb J: 2006; 4 3
52. Gosselin RC, King JH, Janatpur KA, Dager WH, Larkin EC, Owings JT. Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing. Arch Pathol Lab Med: 2004; 128 10 1142 1145 (Pubitemid 39313368)
53. Genzen JR, Miller JL. Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing. Am J Clin Pathol: 2005; 124 4 586 593 (Pubitemid 41395640)
54. Favaloro EJ, Posen J, Ramakrishna R., et al. Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation. Blood Coagul Fibrinolysis: 2004; 15 8 637 647 (Pubitemid 39612969)
55. Tripodi A, Mancuso ME, Chantarangkul V., et al. Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII: considerations on the differentiation between the 2 circulating anticoagulants. Clin Chem: 2005; 51 10 1883 1885 (Pubitemid 41368179)
56. Ballard HS, Nyamuswa G. Life-threatening haemorrhage in a patient with rheumatoid arthritis and a lupus anticoagulant coexisting with acquired autoantibodies against factor VIII. Br J Rheumatol: 1993; 32 6 515 517 (Pubitemid 23193409)
57. Saxena R, Dhot PS, Saraya AK, Singh H, Malhotra OP. Simultaneous occurrence of factor VIIIC inhibitor and lupus anticoagulant. Am J Hematol: 1993; 42 2 232 233 (Pubitemid 23062184)
58. Blanco AN, Alcira Peirano A, Grosso SH, Gennari LC, Prez Bianco R, Lazzari MA. A chromogenic substrate method for detecting and titrating anti-factor VIII antibodies in the presence of lupus anticoagulant. Haematologica: 2002; 87 3 271 278 (Pubitemid 34212443)